We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




B. Braun’s New IV Catheter with One-time Blood Control Makes IV Access Safer for Clinicians

By HospiMedica International staff writers
Posted on 13 Jul 2022
Print article
Image: The Introcan Safety 2 IV Catheter reduces risk of needlestick injuries (Photo courtesy of B. Braun)
Image: The Introcan Safety 2 IV Catheter reduces risk of needlestick injuries (Photo courtesy of B. Braun)

IV access is a critical element of infusion therapy, and this invasive procedure continues to be associated with potential risks to clinicians. Needlestick injuries are one of the highest risks clinicians face during their daily routine. Not only are healthcare workers concerned about needlestick injuries, but also mucocutaneous blood exposure when starting an IV. Every blood exposure carries a risk of infection. Anytime there's blood leakage, clinicians are at risk for exposure to various bloodborne pathogen infections including, but not limited to, HIV, hepatitis B, and hepatitis C. Now, a new IV catheter makes IV access safer for clinicians by reducing the risk of needlestick injuries and their exposure to blood.

B. Braun Medical Inc. (Bethlehem, PA, USA) has launched its new Introcan Safety 2 IV Catheter with one-time blood control that ensures clinicians are protected by a truly automatic passive safety device. Studies show that passive, fully automatic safety devices are two times better than a semi-automatic 'push-button' safety shield and three times better than a manually sliding shield. Introcan Safety 2 helps to reduce clinician and patient's exposure to blood with its one-time Blood Control Septum, which is designed to restrict the flow of blood from the catheter hub after needle removal until first connection of a Luer access device.

"We are excited to broaden our portfolio within the Introcan family of passive safety IV Catheters," said Chad Laity, Director of Marketing, Vascular Access and IV Systems. "The newly launched Introcan Safety 2 will allow clinicians to experience passive needlestick prevention and a reduced risk of exposure to blood borne pathogens when removing the introducer needle from the Introcan Safety 2. This is all achieved with a product similarly sized to the widely popular Introcan Safety Catheter."

Related Links:
B. Braun Medical Inc.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Electric Bariatric Patient Lifter
SVBL 205

Print article

Channels

Surgical Techniques

view channel
Image: Miniaturized electric generators based on hydrogels for use in biomedical devices (Photo courtesy of HKU)

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices

The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.